Vor Biopharma Inc.

VOR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G/A May 15, 2026
SCHEDULE 13G/A May 15, 2026
10-Q May 13, 2026 10-Q
EFFECT May 6, 2026
SCHEDULE 13G/A May 6, 2026
SCHEDULE 13G/A May 6, 2026
CORRESP May 4, 2026
UPLOAD May 1, 2026
S-3 Apr 27, 2026 S-3
ARS Apr 27, 2026 ARS
DEFA14A Apr 27, 2026 DEFA14A
DEF 14A Apr 27, 2026 DEF 14A
4 Apr 24, 2026
SCHEDULE 13D/A Apr 21, 2026
4 Apr 21, 2026
SCHEDULE 13D/A Apr 15, 2026
4 Apr 15, 2026
SCHEDULE 13D/A Apr 10, 2026
4 Apr 10, 2026
3 Apr 9, 2026 3
SCHEDULE 13D/A Apr 8, 2026
4 Apr 6, 2026
SCHEDULE 13G Apr 1, 2026
3 Apr 1, 2026 3
SCHEDULE 13D/A Apr 1, 2026
← Newer Page 2 of 19 · 459 filings Older →